Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1081 | 1082 | (Page 1083) | 1084 | 1085 | .... | 1118 | newer

    0 0

     



    (EMAILWIRE.COM, October 11, 2018 ) The global market size of Protection Gloves for Pharmaceutical Applications Market is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

    There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

    For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:
    *North America
    *South America
    *Asia & Pacific
    *Europe
    *MEA (Middle East and Africa)

    Get Sample Copy of this Report at https://www.researchreportsinc.com/sample-request?id=67428

    The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

    For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

    For competitor segment, the report includes global key players of Protection Gloves for Pharmaceutical Applications as well as some small players. The compnaies include:

    AMMEX, Ansell, ARISTA, BLUESAIL, Cardinal Health, COMASEC, Dengsheng, Dynarex, Dyneema, Globus, Hartalega, HL Rubber Industries, Honeywell, HONGRAY, Ironclad, Jaysun Glove, Jiangsu Cureguard Glove, Ki et al.

    The information for each competitor includes:
    *Company Profile
    *Main Business Information
    *SWOT Analysis
    *Sales, Revenue, Price and Gross Margin
    *Market Share

    Table of Content
    TABLE OF CONTENTS
    Chapter 1 Executive Summary

    Chapter 2 Abbreviation and Acronyms

    Chapter 3 Preface
    3.1 Research Scope
    3.2 Research Methodology
    3.2.1 Data Collection
    3.2.2 Data Analysis
    3.2.3 Data Validation
    3.3 Research Sources
    3.3.1 Primary Sources
    3.3.2 Secondary Sources
    3.3.3 Assumptions

    Chapter 4 Market Landscape
    4.1 Market Overview
    4.2 Classification/Types
    4.3 Application/End Users

    Chapter 5 Market Trend Analysis
    5.1 Introduction
    5.2 Drivers
    5.3 Restraints
    5.4 Opportunities
    5.5 Threats
    Chapter 6 Industry Chain Analysis
    6.1 Upstream/Suppliers Analysis
    6.2 Protection Gloves for Pharmaceutical Applications Analysis
    6.2.1 Technology Analysis
    6.2.2 Cost Analysis
    6.2.3 Market Channel Analysis
    6.3 Downstream Buyers/End Users

    Chapter 7 Latest Market Dynamics
    7.1 Latest News
    7.2 Merger and Acquisition
    7.3 Planned/Future Project
    7.4 Policy Dynamics

    Chapter 8 Trading Analysis
    8.1 Export of Protection Gloves for Pharmaceutical Applications by Region
    8.2 Import of Protection Gloves for Pharmaceutical Applications by Region
    8.3 Balance of Trade

    Chapter 9 Historical and Current Protection Gloves for Pharmaceutical Applications Market in North America (2013-2018)
    9.1 Protection Gloves for Pharmaceutical Applications Supply
    9.2 Protection Gloves for Pharmaceutical Applications Demand by End Use
    9.3 Competition by Players/Suppliers
    9.4 Type Segmentation and Price
    9.5 Key Countries Analysis

    Chapter 10 Historical and Current Protection Gloves for Pharmaceutical Applications Market in South America (2013-2018)
    10.1 Protection Gloves for Pharmaceutical Applications Supply
    10.2 Protection Gloves for Pharmaceutical Applications Demand by End Use
    10.3 Competition by Players/Suppliers
    10.4 Type Segmentation and Price
    10.5 Key Countries Analysis

    Chapter 11 Historical and Current Protection Gloves for Pharmaceutical Applications Market in Asia & Pacific (2013-2018)
    11.1 Protection Gloves for Pharmaceutical Applications Supply
    11.2 Protection Gloves for Pharmaceutical Applications Demand by End Use
    11.3 Competition by Players/Suppliers
    11.4 Type Segmentation and Price
    11.5 Key Countries Analysis

    Chapter 12 Historical and Current Protection Gloves for Pharmaceutical Applications Market in Europe (2013-2018)
    12.1 Protection Gloves for Pharmaceutical Applications Supply
    12.2 Protection Gloves for Pharmaceutical Applications Demand by End Use
    12.3 Competition by Players/Suppliers
    12.4 Type Segmentation and Price
    12.5 Key Countries Analysis

    Chapter 13 Historical and Current Protection Gloves for Pharmaceutical Applications Market in MEA (2013-2018)
    13.1 Protection Gloves for Pharmaceutical Applications Supply
    13.2 Protection Gloves for Pharmaceutical Applications Demand by End Use
    13.3 Competition by Players/Suppliers
    13.4 Type Segmentation and Price
    13.5 Key Countries Analysis

    Chapter 14 Summary for Global Protection Gloves for Pharmaceutical Applications Market (2013-2018)
    14.1 Protection Gloves for Pharmaceutical Applications Supply
    14.2 Protection Gloves for Pharmaceutical Applications Demand by End Use
    14.3 Competition by Players/Suppliers
    14.4 Type Segmentation and Price

    Chapter 15 Global Protection Gloves for Pharmaceutical Applications Market Forecast (2019-2023)
    15.1 Protection Gloves for Pharmaceutical Applications Supply Forecast
    15.2 Protection Gloves for Pharmaceutical Applications Demand Forecast
    15.3 Competition by Players/Suppliers
    15.4 Type Segmentation and Price Forecast

    Chapter 16 Company Profile(AMMEX, Ansell, ARISTA, BLUESAIL, Cardinal Health, COMASEC, Dengsheng, Dynarex, Dyneema, Globus, Hartalega, HL Rubber Industries, Honeywell, HONGRAY, Ironclad, Jaysun Glove, Jiangsu Cureguard Glove, Ki et al.)
    16.1 Company A
    16.1.1 Company Profile
    16.1.2 Main Business and Protection Gloves for Pharmaceutical Applications Information
    16.1.3 SWOT Analysis of Company A
    16.1.4 Company A Protection Gloves for Pharmaceutical Applications Sales, Revenue, Price and Gross Margin (2013-2018)

    Have Any Query? Ask Our Experts @ https://researchreportsinc.com/enquiry?id=67428

    We also can offer customized report to fulfill special requirements of our clients.


    Shubham Goel
    8554192424
    sales@researchreportsinc.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 11, 2018 ) The global market size of Pulmonary Arterial Hypertension (PAH) Therapeutics Market is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

    There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

    For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report covers following regions:
    *North America
    *South America
    *Asia & Pacific
    *Europe
    *MEA (Middle East and Africa)

    Get Sample Copy of this Report at https://www.researchreportsinc.com/sample-request?id=67432

    The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

    For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

    For competitor segment, the report includes global key players of Pulmonary Arterial Hypertension (PAH) Therapeutics as well as some small players. The companies include:

    Actelion Pharmaceuticals Ltd. (Switzerland), Arena Pharmaceuticals, Inc. (US), Bayer HealthCare Pharmaceuticals (Germany), Cipla Limited (India), Daiichi Sankyo Co., Ltd. (Japan), Eli Lilly and Compa et al.

    The information for each competitor includes:
    *Company Profile
    *Main Business Information
    *SWOT Analysis
    *Sales, Revenue, Price and Gross Margin
    *Market Share

    TABLE OF CONTENTS
    Chapter 1 Executive Summary

    Chapter 2 Abbreviation and Acronyms

    Chapter 3 Preface
    3.1 Research Scope
    3.2 Research Methodology
    3.2.1 Data Collection
    3.2.2 Data Analysis
    3.2.3 Data Validation
    3.3 Research Sources
    3.3.1 Primary Sources
    3.3.2 Secondary Sources
    3.3.3 Assumptions

    Chapter 4 Market Landscape
    4.1 Market Overview
    4.2 Classification/Types
    4.3 Application/End Users

    Chapter 5 Market Trend Analysis
    5.1 Introduction
    5.2 Drivers
    5.3 Restraints
    5.4 Opportunities
    5.5 Threats
    Chapter 6 Industry Chain Analysis
    6.1 Upstream/Suppliers Analysis
    6.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Analysis
    6.2.1 Technology Analysis
    6.2.2 Cost Analysis
    6.2.3 Market Channel Analysis
    6.3 Downstream Buyers/End Users

    Chapter 7 Latest Market Dynamics
    7.1 Latest News
    7.2 Merger and Acquisition
    7.3 Planned/Future Project
    7.4 Policy Dynamics

    Chapter 8 Trading Analysis
    8.1 Export of Pulmonary Arterial Hypertension (PAH) Therapeutics by Region
    8.2 Import of Pulmonary Arterial Hypertension (PAH) Therapeutics by Region
    8.3 Balance of Trade

    Chapter 9 Historical and Current Pulmonary Arterial Hypertension (PAH) Therapeutics Market in North America (2013-2018)
    9.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply
    9.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand by End Use
    9.3 Competition by Players/Suppliers
    9.4 Type Segmentation and Price
    9.5 Key Countries Analysis

    Chapter 10 Historical and Current Pulmonary Arterial Hypertension (PAH) Therapeutics Market in South America (2013-2018)
    10.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply
    10.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand by End Use
    10.3 Competition by Players/Suppliers
    10.4 Type Segmentation and Price
    10.5 Key Countries Analysis

    Chapter 11 Historical and Current Pulmonary Arterial Hypertension (PAH) Therapeutics Market in Asia & Pacific (2013-2018)
    11.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply
    11.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand by End Use
    11.3 Competition by Players/Suppliers
    11.4 Type Segmentation and Price
    11.5 Key Countries Analysis

    Chapter 12 Historical and Current Pulmonary Arterial Hypertension (PAH) Therapeutics Market in Europe (2013-2018)
    12.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply
    12.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand by End Use
    12.3 Competition by Players/Suppliers
    12.4 Type Segmentation and Price
    12.5 Key Countries Analysis

    Chapter 13 Historical and Current Pulmonary Arterial Hypertension (PAH) Therapeutics Market in MEA (2013-2018)
    13.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply
    13.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand by End Use
    13.3 Competition by Players/Suppliers
    13.4 Type Segmentation and Price
    13.5 Key Countries Analysis

    Chapter 14 Summary for Global Pulmonary Arterial Hypertension (PAH) Therapeutics Market (2013-2018)
    14.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply
    14.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand by End Use
    14.3 Competition by Players/Suppliers
    14.4 Type Segmentation and Price

    Chapter 15 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Market Forecast (2019-2023)
    15.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply Forecast
    15.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand Forecast
    15.3 Competition by Players/Suppliers
    15.4 Type Segmentation and Price Forecast

    Chapter 16 Company Profile(Actelion Pharmaceuticals Ltd. (Switzerland), Arena Pharmaceuticals, Inc. (US), Bayer Health Care Pharmaceuticals (Germany), Cipla Limited (India), Daiichi Sankyo Co., Ltd. (Japan), Eli Lilly and Compa et al.)
    16.1 Company A
    16.1.1 Company Profile

    Have Any Query? Ask Our Experts @ https://researchreportsinc.com/enquiry?id=67432

    We also can offer customized report to fulfill special requirements of our clients.


    Shubham Goel
    8554192424
    sales@researchreportsinc.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 11, 2018 ) Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.

    This research study presents an all-inclusive assessment of the global Cancer Stem Cell Market, considering various industry parameters, such as the manufacturing capacity, product pricing, demand, supply, sales dynamics, returns on investments (RoI), and the growth rate of the overall market. The main objective of this research study is to provide a clear understanding of the global Cancer Stem Cell market to the participants and assist them in creating crucial strategies to gain an edge over their competitors.

    Get Sample Copy of this Report @ https://www.researchbeam.com/global-cancer-stem-cell-2018-by-manufacturers-countries-type-and-application-forecast-to-2023-market/request-sample

    Scope of the Report:
    This report studies the Cancer Stem Cell market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Stem Cell market by product type and applications/end industries.

    North America was the leading revenue contributor of the cancer stem cells market in 2016 due to presence of a substantial number of organizations engaged in conducting R&D activities related to stem cell therapy. There are several internationally recognized hospitals and medical institutes, such as Cancer Treatment Centers of America at Midwestern Regional Medical Center, which offer stem cell transplant therapies.

    Asia Pacific is expected to be a promising region in the arena owing to presence of several organizations in the region that focus on R&D of stem cells. Moreover, funding agencies are providing grants to research communities to accelerate their scientific research on cancer stem cells in Asian countries.

    Market Segment by Companies, this report covers: Thermo Fisher Scientific, Inc., AbbVie, Inc., Merck KGaA, Bionomics, Lonza, Stemline Therapeutics, Inc., Miltenyi Biotec, PromoCell GmbH, MacroGenics, Inc., OncoMed Pharmaceuticals, Inc., Irvine Scientific, STEMCELL Technologies Inc., Sino Biological Inc., BIOTIME, Inc.

    Market Segment by Regions, regional analysis covers
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa

    Get a discount on this research report @ https://www.researchbeam.com/global-cancer-stem-cell-2018-by-manufacturers-countries-type-and-application-forecast-to-2023-market/purchase-enquiry

    Market Segment by Type, covers
    • Cell Culturing
    • Cell Separation
    • Cell Analysis
    • Molecular Analysis
    • Others

    Market Segment by Applications, can be divided into
    • Stem Cell Based Cancer Therapy
    • Targeted CSCs

    There are 15 Chapters to deeply display the global Cancer Stem Cell market.
    • Chapter 1, to describe Cancer Stem Cell Introduction, product scope, market overview, market opportunities, market risk, market driving force;
    • Chapter 2, to analyze the top manufacturers of Cancer Stem Cell, with sales, revenue, and price of Cancer Stem Cell, in 2016 and 2017;
    • Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
    • Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Stem Cell, for each region, from 2013 to 2018;
    • Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
    • Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
    • Chapter 12, Cancer Stem Cell market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
    • Chapter 13, 14 and 15, to describe Cancer Stem Cell sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

    Access full report Description, TOC and Table of Figure @: https://www.researchbeam.com/global-cancer-stem-cell-2018-by-manufacturers-countries-type-and-application-forecast-to-2023-market

    About Us:

    Research Beam is a high end and wide online market for market research reports that contain detailed and rational market research. Research Beam is a one stop report destination that offers clients well drafted and accurately analyzed report with insightful data.

    Contact Us
    Global Head Quarters
    5933 NE Win Sivers Drive,
    #205, Portland, OR 97220
    United States
    +1 (800) 910-6452
    help@researchbeam.com



    Research Beam
    +1 (800) 910-6452
    help@researchbeam.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 11, 2018 ) By improving maintenance practices, helping hospitals be more compliant to industry standards, and ensuring robust sanitation and tracking methods, hospital assest management methods can increase its productivity and improve patient prospects dramatically.

    A report titled “Global Hospital Asset Management Market” has been lately added to the Research Beam’s extensive database. Their repository depicts the expert documentation of reports based on different markets and Global Hospital Asset Management Market is one of them. This survey has outlined some of the key trends, promising advancements that the future holds, growing opportunities, latest technological advancements, and competitive landscape in major regions. It estimates the growth rate of various segments over the forecast period (2023).

    Get Sample Copy of this Report @ https://www.researchbeam.com/global-hospital-asset-management-2018-by-manufacturers-countries-type-and-application-forecast-to-2023-market/request-sample

    Scope of the Report:
    This report studies the Hospital Asset Management market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hospital Asset Management market by product type and applications/end industries.

    Global hospital asset management market is expected to witness a lucrative growth during the forecast period owing to the increasing incidences of drug counterfeiting along with rising issues in supply chain management.

    The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
    North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hospital Asset Management.

    Market Segment by Companies, this report covers: Tyco international Ltd., IBM corporation, Awarepoint corporation, Infor, Motorola solutions Inc., GE healthcare, Ekahau Inc., Siemens healthcare, Vizbee RFID systems Ltd., Sonitor technologies Inc., Versus technology Inc., Zebra technologies corporation, Trimble navigation Ltd, AeroScout Inc.

    Market Segment by Regions, regional analysis covers
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa

    Get a discount on this research report @ https://www.researchbeam.com/global-hospital-asset-management-2018-by-manufacturers-countries-type-and-application-forecast-to-2023-market/purchase-enquiry

    Market Segment by Type, covers
    • Real-time location systems (RTLS)
    • Radio-frequency identification (RFID)
    • Ultrasound
    • Infrared

    Market Segment by Applications, can be divided into
    • Patient management
    • Staff management
    • Instrument management
    • Supply chain management

    There are 15 Chapters to deeply display the global Hospital Asset Management market.
    • Chapter 1, to describe Hospital Asset Management Introduction, product scope, market overview, market opportunities, market risk, market driving force;
    • Chapter 2, to analyze the top manufacturers of Hospital Asset Management, with sales, revenue, and price of Hospital Asset Management, in 2016 and 2017;
    • Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
    • Chapter 4, to show the global market by regions, with sales, revenue and market share of Hospital Asset Management, for each region, from 2013 to 2018;
    • Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
    • Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
    • Chapter 12, Hospital Asset Management market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
    • Chapter 13, 14 and 15, to describe Hospital Asset Management sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

    Access full report Description, TOC and Table of Figure @: https://www.researchbeam.com/global-hospital-asset-management-2018-by-manufacturers-countries-type-and-application-forecast-to-2023-market

    About Us:

    Research Beam is a high end and wide online market for market research reports that contain detailed and rational market research. Research Beam is a one stop report destination that offers clients well drafted and accurately analyzed report with insightful data.


    Contact Us
    Global Head Quarters
    5933 NE Win Sivers Drive,
    #205, Portland, OR 97220
    United States
    +1 (800) 910-6452
    help@researchbeam.com



    Research Beam
    +1 (800) 910-6452
    help@researchbeam.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 16, 2018 ) Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2018, provides an overview of the Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline landscape.

    Lassa fever is an acute viral hemorrhagic illness caused by Lassa virus, a member of the arena virus family of viruses. It is transmitted to humans from contacts with food or household items contaminated with rodent excreta. Symptoms include fever, headache, chills, back pain, weight loss, swollen neck, rashes and bleeding.

    Key Players:
    • Celgene Corp
    • Etubics Corp
    • GeoVax Labs Inc
    • Inovio Pharmaceuticals Inc
    • Kineta Inc
    • Profectus BioSciences Inc
    • Themis Bioscience GmbH
    • Toyama Chemical Co Ltd

    Get Sample Copy of this Report@ http://www.orbisresearch.com/contacts/request-sample/2332474

    Report Highlights:
    Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lassa Fever (Lassa Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase I, Preclinical, Discovery and Unknown stages are 1, 9, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively.

    Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Make an Inquiry before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2332474

    Scope:
    - The pipeline guide provides a snapshot of the global therapeutic landscape of Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease).
    - The pipeline guide reviews pipeline therapeutics for Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease)

    Reasons to buy:
    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease).
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

    Get More Access with Full TOC@ http://www.orbisresearch.com/reports/index/lassa-fever-lassa-hemorrhagic-fever-pipeline-review-h2-2018

    About Us:

    Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.


    Hector Costello
    +1 (214) 884-6817
    sales@orbisresearch.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 16, 2018 ) Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2018, provides an overview of the Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline landscape.

    Epstein-Barr virus (EBV) or human herpes virus 4 virus is a member of the Herpesviridae family. It is one of the most common human viruses to cause cancer in humans and is associated with a wide range of human cancers originating from epithelial cells, lymphocytes and mesenchymal cells. It spreads most commonly through bodily fluids. It can also spread through blood and semen during sexual contact, blood transfusions, and organ transplantations. Symptoms of EBV infections include fatigue, fever, and inflamed throat, swollen lymph nodes in the neck, enlarged spleen, swollen liver and rash. Treatment includes over-the-counter pain and fever medications to get relief from the symptoms of the disease.

    Key Players:
    • Advenchen Laboratories LLC
    • Atara Biotherapeutics Inc
    • Biotron Ltd
    • bluebird bio Inc
    • Bristol-Myers Squibb Co
    • Cell Medica Ltd
    • Genocea Biosciences Inc
    • Omeros Corp
    • Ono Pharmaceutical Co Ltd
    • Oxford Vacmedix UK Ltd
    • TC BioPharm Ltd
    • Tessa Therapeutics Pte Ltd
    • Vectorite Biomedical Inc
    • Viracta Therapeutics Inc
    • Vironika LLC
    • ViroStatics srl

    Get Sample Copy of this Report@ http://www.orbisresearch.com/contacts/request-sample/2332476

    Report Highlights:
    Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Epstein-Barr Virus (HHV-4) Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Epstein-Barr Virus (HHV-4) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 8, 4, 9 and 7 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 9, 2, 5 and 4 molecules, respectively.

    Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Make an Inquiry before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2332476

    Scope:
    - The pipeline guide provides a snapshot of the global therapeutic landscape of Epstein-Barr Virus (HHV-4) Infections (Infectious Disease).
    - The pipeline guide reviews pipeline therapeutics for Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Epstein-Barr Virus (HHV-4) Infections (Infectious Disease)

    Reasons to buy:
    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Epstein-Barr Virus (HHV-4) Infections (Infectious Disease).
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

    Get More Access with Full TOC@ http://www.orbisresearch.com/reports/index/epstein-barr-virus-hhv-4-infections-pipeline-review-h2-2018

    About Us:

    Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.


    Hector Costello
    +1 (214) 884-6817
    sales@orbisresearch.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 16, 2018 ) Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2018, provides an overview of the Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline landscape.

    Paroxysmal nocturnal hemoglobinuria is a rare disease in which red blood cells break down earlier than normal. Symptoms include abdominal pain, back pain, dark urine, easy bruising or bleeding, headache and shortness of breath. The predisposing factors include age, obesity and hormone therapy. Treatment includes surgery, chemotherapy and radiation therapy.

    Key Players:
    • Achillion Pharmaceuticals Inc
    • Akari Therapeutics Plc
    • Alexion Pharmaceuticals Inc
    • Alnylam Pharmaceuticals Inc
    • Amgen Inc
    • Apellis Pharmaceuticals Inc
    • Chugai Pharmaceutical Co Ltd
    • ISU ABXIS Co Ltd
    • Novartis AG
    • NovelMed Therapeutics Inc
    • Omeros Corp
    • Ra Pharmaceuticals Inc
    • Regeneron Pharmaceuticals Inc

    Get Sample Copy of this Report@ http://www.orbisresearch.com/contacts/request-sample/2332478

    Report Highlights:
    Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Paroxysmal Nocturnal Hemoglobinuria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 3, 6, 4, 1, 8 and 1 respectively.

    Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Make an Inquiry before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2332478

    Scope:
    - The pipeline guide provides a snapshot of the global therapeutic landscape of Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders).
    - The pipeline guide reviews pipeline therapeutics for Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders)

    Reasons to buy:
    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders).
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

    Get More Access with Full TOC@ http://www.orbisresearch.com/reports/index/paroxysmal-nocturnal-hemoglobinuria-pipeline-review-h2-2018

    About Us:

    Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.


    Hector Costello
    +1 (214) 884-6817
    sales@orbisresearch.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 16, 2018 ) Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acromegaly - Pipeline Review, H2 2018, provides an overview of the Acromegaly (Hormonal Disorders) pipeline landscape.

    Acromegaly is a hormonal disorder that develops when pituitary gland produces too much growth hormone during adulthood. Symptoms include body odor, easy fatigue, headache, large feet, excessive height, swelling of the bony areas around a joint, widely spaced teeth and sleep apnea. Treatment includes surgery, dopamine agonists and growth hormone antagonists.

    Key Players:
    • Aegis Therapeutics LLC
    • Amryt Pharma plc
    • Antisense Therapeutics Ltd
    • Aquestive Therapeutics Inc
    • Auritec Pharmaceuticals Inc
    • Camurus AB
    • Chiasma Inc
    • Crinetics Pharmaceuticals Inc
    • Daewoong Pharmaceutical Co Ltd
    • Dauntless Pharmaceuticals Inc
    • DexTech Medical AB
    • GeneScience Pharmaceuticals Co Ltd
    • Ionis Pharmaceuticals Inc
    • Italfarmaco SpA
    • leon-nanodrugs GmbH
    • Midatech Pharma Plc
    • Ono Pharmaceutical Co Ltd
    • Strongbridge Biopharma plc
    • Sun Pharma Advanced Research Company Ltd

    Get Sample Copy of this Report@ http://www.orbisresearch.com/contacts/request-sample/2332480

    Report Highlights:
    Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Acromegaly - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Acromegaly (Hormonal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Acromegaly (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Acromegaly and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 7, 5, 7 and 3 respectively.

    Acromegaly (Hormonal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Make an Inquiry before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2332480

    Scope:
    - The pipeline guide provides a snapshot of the global therapeutic landscape of Acromegaly (Hormonal Disorders).
    - The pipeline guide reviews pipeline therapeutics for Acromegaly (Hormonal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Acromegaly (Hormonal Disorders) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Acromegaly (Hormonal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Acromegaly (Hormonal Disorders)

    Reasons to buy:
    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Acromegaly (Hormonal Disorders).
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Acromegaly (Hormonal Disorders) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

    Get More Access with Full TOC@ http://www.orbisresearch.com/reports/index/acromegaly-pipeline-review-h2-2018

    About Us:

    Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.


    Hector Costello
    +1 (214) 884-6817
    sales@orbisresearch.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, October 16, 2018 ) Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Drug Overdose - Pipeline Review, H2 2018, provides an overview of the Drug Overdose (Toxicology) pipeline landscape.

    Drug overdoses occur when a person takes more than the medically recommended dose of a prescription or over-the-counter drug. It can be either accidental or intentional. Symptoms include sleepiness, confusion, chest pain, seizures, abdominal pain, nausea, vomiting, and diarrhea. Risk factors include age, gender, mental illness and history of overdose. Treatment includes antidote and activated charcoal.

    Key Players:
    • Adamis Pharmaceuticals Corp
    • Adapt Pharma Ltd
    • Crossject SA
    • Fab’entech SA
    • Icure Pharmaceutical Inc
    • Insys Therapeutics Inc
    • Klaria Pharma Holding AB
    • Opiant Pharmaceuticals Inc
    • Orexo AB
    • PledPharma AB

    Get Sample Copy of this Report@ http://www.orbisresearch.com/contacts/request-sample/2332484

    Report Highlights:
    Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Drug Overdose - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Drug Overdose (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Drug Overdose (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Drug Overdose and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 2, 1, 2, 1, 3, 2 and 6 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.

    Drug Overdose (Toxicology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Make an Inquiry before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2332484

    Scope:
    - The pipeline guide provides a snapshot of the global therapeutic landscape of Drug Overdose (Toxicology).
    - The pipeline guide reviews pipeline therapeutics for Drug Overdose (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Drug Overdose (Toxicology) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Drug Overdose (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Drug Overdose (Toxicology)

    Reasons to buy:
    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Drug Overdose (Toxicology).
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Drug Overdose (Toxicology) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

    Get More Access with Full TOC@ http://www.orbisresearch.com/reports/index/drug-overdose-pipeline-review-h2-2018

    About Us:

    Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.


    Hector Costello
    +1 (214) 884-6817
    sales@orbisresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Moist Snuff Market Report for 2018-2023.
    Moist snuff is a smokeless tobacco product that is consumed by placing it into mouth between the lip and the gum.
    Over the next five years, Expert projects that Moist Snuff will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    This report presents a comprehensive overview, market shares, and growth opportunities of Moist Snuff market by product type, application, key manufacturers and key regions.

    Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/RCG/QBI-LPI-RCG-58954

    To calculate the market size, Expert considers value generated from the sales of the following segments:

    Segmentation by product type:
    Fruit Flavors
    Mint Flavors
    Segmentation by application:
    Offline
    Online

    This report also splits the market by region:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    For Enquiry, Visit@ https://www.qurateresearch.com/report/sample/RCG/QBI-LPI-RCG-58954

    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
    Swedish Match
    American Snuff Company
    Copenhagen
    Skoal
    Timberwolf
    Husky
    ...

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Research objectives
    To study and analyze the global Moist Snuff consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Moist Snuff market by identifying its various subsegments.
    Focuses on the key global Moist Snuff manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Moist Snuff with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Moist Snuff submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

    Direct Purchase@ https://www.qurateresearch.com/report/buy/RCG/QBI-LPI-RCG-58954/


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Nicotine Pouches Market Report for 2018-2023.
    Nicotine Pouches are tobacco derived nicotine products that come with a chewing gum base and the nicotine is extracted from the plant nicotiana tabacum.
    Over the next five years, Expert projects that Nicotine Pouches will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    This report presents a comprehensive overview, market shares, and growth opportunities of Nicotine Pouches market by product type, application, key manufacturers and key regions.

    Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/RCG/QBI-LPI-RCG-58955

    To calculate the market size, Expert considers value generated from the sales of the following segments:

    Segmentation by product type:
    Fruit Flavours
    Mint Flavours
    Segmentation by application:
    Offline
    Online

    This report also splits the market by region:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    For Enquiry, Visit@ https://www.qurateresearch.com/report/sample/RCG/QBI-LPI-RCG-58955

    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
    Swedish Match
    Chill of Sweden, Inc.
    Dryft
    The Art Factory AB (POSE)

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Research objectives
    To study and analyze the global Nicotine Pouches consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Nicotine Pouches market by identifying its various subsegments.
    Focuses on the key global Nicotine Pouches manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    Direct Purchase@ https://www.qurateresearch.com/report/buy/RCG/QBI-LPI-RCG-58955/


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Chewing Tobacco Market Report for 2018-2023.
    Chewing tobacco is a type of tobacco derived product that placed between the cheek and gum. It usually packaged either as loose tobacco leaves, leaves compressed into a small, brick-like shape called a plug, or braids of leaves called a twist.
    Over the next five years, Expert projects that Chewing Tobacco will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    This report presents a comprehensive overview, market shares, and growth opportunities of Chewing Tobacco market by product type, application, key manufacturers and key regions.

    Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/RCG/QBI-LPI-RCG-58956

    To calculate the market size, Expert considers value generated from the sales of the following segments:

    Segmentation by product type:
    Fruit Flavours
    Mint Flavours
    Segmentation by application:
    Offline
    Online

    This report also splits the market by region:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    For Enquiry, Visit@ https://www.qurateresearch.com/report/enquiry/RCG/QBI-LPI-RCG-58956

    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
    Swedish Match
    Tough Guy
    Stoker's Chew
    J.D's Blend
    Levi Garrett
    Beech-Nut
    Starr
    ...

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Research objectives
    To study and analyze the global Chewing Tobacco consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Chewing Tobacco market by identifying its various subsegments.
    Focuses on the key global Chewing Tobacco manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    Direct Purchase@ https://www.qurateresearch.com/report/buy/RCG/QBI-LPI-RCG-58956/


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Snuff Market Report for 2018-2023.
    Snuff is finely cut or ground tobacco.
    Over the next five years, Expert projects that Snuff will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    This report presents a comprehensive overview, market shares, and growth opportunities of Snuff market by product type, application, key manufacturers and key regions.

    Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/RCG/QBI-LPI-RCG-58957

    To calculate the market size, Expert considers value generated from the sales of the following segments:

    Segmentation by product type:
    Moist Snuff
    Dry Snuff
    Segmentation by application:
    Supermarket
    Tobacco Store
    Online

    This report also splits the market by region:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    For Enquiry, Visit@ https://www.qurateresearch.com/report/enquiry/RCG/QBI-LPI-RCG-58957

    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
    Swedish Match
    American Snuff Company
    Copenhagen
    Skoal
    Timberwolf
    Husky
    Imperial Tobacco Group
    Reynolds American
    British American Tobacco
    Japan Tobacco
    Altria

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Research objectives
    To study and analyze the global Snuff consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Snuff market by identifying its various subsegments.
    Focuses on the key global Snuff manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    Direct Purchase@ https://www.qurateresearch.com/report/buy/RCG/QBI-LPI-RCG-58957/



    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 16, 2018 ) Overview:

    Health Analytics encompasses several technologies, methods, and skills used to synthesize and analyze health care data from a wide range of health industries, in order to disentangle trends and gain ideas for improving health care outcomes. The analysis of medical care has increasingly played a vital role in health systems around the world to improve patient outcomes and improve the quality of care at an affordable cost. On the other hand, health care analysis provides health institutions with crucial knowledge about income and risk models.

    View sample and decide: https://www.marketdataforecast.com/market-reports/asia-pacific-healthcare-analytics-market-53/request-sample

    Asia Pacific Healthcare Analytics Market size was around USD 1.79 billion in 2018. It is expected to grow at a CAGR of 19.85% to reach USD 4.42 billion by 2023.

    Drivers and Restraints:

    Incorporation of big analytics in the medical field, technological advancements, continuous government initiatives, high developed infrastructure, concerns about confidentiality of information, better quality outcomes. Restraints of the market are cultural barriers, dearth of skilled workforce and security issues.

    To know more read: https://www.marketdataforecast.com/market-reports/asia-pacific-healthcare-analytics-market-53/

    Geographic Segmentation

    The Asia Pacific Healthcare Analytics market has geographically segmented into China, India, Japan, South Korea, and Australia. Asia market is the fastest growing market.

    Get your customized report: https://www.marketdataforecast.com/market-reports/asia-pacific-healthcare-analytics-market-53/customize-report

    Major companies in the market are SAS Institute, Inc., Optum, Inc., IBM Corporation, Truven Health Analytics Inc., Cerner Corporation, Verisk Analytics, Inc., McKesson Corporation, Allscripts Health Solutions, Oracle Corporation, MedeAnalytics, Inovalon, Inc. and Health Catalyst.

    Scope of the report:

    The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

    The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

    What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

    Contact Info:
    Name: Mr. Abhishek Shukla
    Email: abhishek@marketdataforecast.com
    Organization: MarketDataForecast™
    Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony,
    Hyderabad, Telangana 500033, India.
    Phone: +1-888-702-9626


    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 16, 2018 ) An array is the technology used in laboratories that quantitatively and simultaneously monitors the expression of thousand genes. The high-throughput approach of microarrays help locate mutations in genotype, measure and detect gene expressions at the mRNA or at the protein level, and locate chromosomal expressions.
    The global array instruments market can be divided into three segments: DNA microarrays, protein microarrays, and others including tissue microarrays and cell microarrays. This report covers the present scenario and the growth prospects of the global array instruments market for the period 2015–2019. To calculate the market size, the report considers revenue generated from sales of three applications used by life sciences companies, R&D institutes, and diagnostic laboratories.
    Over the next five years, Expert projects that Array Instruments will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/CnM/QBI-LPI-CnM-58875

    This report presents a comprehensive overview, market shares, and growth opportunities of Array Instruments market by product type, application, key manufacturers and key regions.

    To calculate the market size, Expert considers value and volume generated from the sales of the following segments:
    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
    Affymetrix
    Agilent Technologies
    Illumina
    Arrayit
    Asterand
    Laboratory Corporation of America Holdings
    OriGene Technologies
    Orla Protein Technologies
    Oxford Gene Technology
    Partek
    Pepscan
    Perkin Elmer
    Phalanx Biotech Group
    ProteoGenix
    Qiagen
    RayBiotech
    Retrogenix
    Luminex
    Meso Scale Diagnostics
    ingyuan Medicare Development Company
    Novus Biologicals

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/CnM/QBI-LPI-CnM-58875


    Segmentation by product type:
    DNA Microarrays
    Protein Microarrays
    Others

    Segmentation by application:
    Molecular Biolog
    Cell Biology
    Genetics
    Molecular Pathology
    Others

    This report also splits the market by region:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries


    Purchase Report@ https://www.qurateresearch.com/report/buy/CnM/QBI-LPI-CnM-58875/

    Research objectives
    To study and analyze the global Array Instruments consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Array Instruments market by identifying its various subsegments.
    Focuses on the key global Array Instruments manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Array Instruments with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Array Instruments submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.



    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 16, 2018 ) Wearable devices are also known as wearable gadgets, wearable technology or simply wearables. A wearable device is a technology that is worn on the human body. This type of device has become a more common part of the tech world as companies have started to evolve more types of devices that are small enough to wear and that include powerful sensor technologies that can collect and deliver information about their surroundings. A wearable device is often used for tracking a user's vital signs or pieces of data related to health and fitness, location or even his/her biofeedback indicating emotions. Wearable device models may rely on short-range wireless systems such as Bluetooth or local Wi-Fi setups.
    Industrial wearable device is designed to improve workplace safety, productivity and efficiency for companies of the industrial sector. These devices must directly aid a worker to perform the task at hand.
    Over the next five years,Expert projects that Industrial Wearable Devices will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/ICT/QBI-LPI-ICT-58877


    This report presents a comprehensive overview, market shares, and growth opportunities of Industrial Wearable Devices market by product type, application, key manufacturers and key regions.

    To calculate the market size, Expert considers value and volume generated from the sales of the following segments:
    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
    Epson
    Vuzix
    Eurotech
    Generalscan
    Honeywell
    Shenzhen Unique Electronic
    Zebra
    ...

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/ICT/QBI-LPI-ICT-58877

    Segmentation by product type:
    Watches
    Fabric
    Glasses
    Fitness Trackers
    Sensors

    Segmentation by application:
    Manufacturing
    Healthcare
    Media and Entertainment
    Sports and Fitness

    This report also splits the market by region:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    Purchase Report@ https://www.qurateresearch.com/report/buy/ICT/QBI-LPI-ICT-58877/


    Research objectives
    To study and analyze the global Industrial Wearable Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Industrial Wearable Devices market by identifying its various subsegments.
    Focuses on the key global Industrial Wearable Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Industrial Wearable Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Industrial Wearable Devices submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.



    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Medical Composites Market Report for 2018-2023.
    The major driver stimulating the medical composites market is high demand from diagnostic imaging.
    North America is projected to be the fastest-growing market for medical composites in the next five years.
    Over the next five years, Expert projects that Medical Composites will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    This report presents a comprehensive overview, market shares, and growth opportunities of Medical Composites market by product type, application, key manufacturers and key regions.

    Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/CnM/QBI-LPI-CnM-58961

    To calculate the market size, Expert considers value generated from the sales of the following segments:

    Segmentation by product type:
    Carbon
    Ceramic
    Glass Fiber
    Segmentation by application:
    Diagnostic Imaging
    Composites Body Implants
    Surgical Instruments
    Denta
    Microsphere
    Tissue Engineering

    This report also splits the market by region:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    For Enquiry, Visit@ https://www.qurateresearch.com/report/enquiry/CnM/QBI-LPI-CnM-58961

    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
    3M (US)
    Royal DSM (Netherlands)
    Royal TenCtae
    Toray Industries(Japan)
    Icotec (Switzerland)
    Mitsubishi Rayon (Japan)
    Composiflex (US)
    Vermont Composites (US)
    ACP Composites (US)
    Quatro Composites (US)

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Research objectives
    To study and analyze the global Medical Composites consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Medical Composites market by identifying its various subsegments.
    Focuses on the key global Medical Composites manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Medical Composites with respect to individual growth trends, future prospects, and their contribution to the total market.

    Direct Purchase@ https://www.qurateresearch.com/report/buy/CnM/QBI-LPI-CnM-58961/


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Medical Imaging Devices Market Report for 2018-2023.
    The medical imaging device industry has been evolving ever since its inception, with assurance of cost and clinical advantages offered furthering access to a range of imaging modalities in several medical applications.
    Over the next five years, Expert projects that Medical Imaging Devices will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    This report presents a comprehensive overview, market shares, and growth opportunities of Medical Imaging Devices market by product type, application, key manufacturers and key regions.

    Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/CnM/QBI-LPI-CnM-58964

    To calculate the market size, Expert considers value generated from the sales of the following segments:

    Segmentation by product type:
    Computer Tomography (CT)
    Magnetic Resonance Imaging (MRI)
    Positron Emission Tomography (PET)
    Ultrasound
    X-Ray
    Others
    Segmentation by application:
    Hospital
    Clinic

    This report also splits the market by region:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    For Enquiry, Visit@ https://www.qurateresearch.com/report/enquiry/CnM/QBI-LPI-CnM-58964

    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
    Philips Healthcare
    GE Healthcare
    Shimadzu
    Varian Medical
    Siemens Healthineers
    Toshiba
    Carestream
    Aribex
    Ziehm

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Research objectives
    To study and analyze the global Medical Imaging Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Medical Imaging Devices market by identifying its various subsegments.
    Focuses on the key global Medical Imaging Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Medical Imaging Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Medical Imaging Devices submarkets, with respect to key regions (along with their respective key countries).

    Direct Purchase@ https://www.qurateresearch.com/report/buy/CnM/QBI-LPI-CnM-58964/


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Lancet and Lancing Devices Market Report for 2018-2023.
    A lancet is a small needle with a plastic or rubber coating that fits into the top of a lancing device. Lancing devices are pen-like instruments which are used in conjunction with a lancet to draw blood to be applied to a glucose strip.
    Over the next five years, expert projects that Lancet and Lancing Devices will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    This report presents a comprehensive overview, market shares, and growth opportunities of Lancet and Lancing Devices market by product type, application, key manufacturers and key regions.

    Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-LPI-HnM-58966

    To calculate the market size, Expert considers value and volume generated from the sales of the following segments:

    Segmentation by product type:
    Safety Lancets
    Homecare Lancets
    Segmentation by application:
    Cholesterol Tests
    Glucose Tests
    Other

    This report also splits the market by region:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    For Enquiry, Visit@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-LPI-HnM-58966

    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
    Roche
    Lifescan
    BD
    Panasonic (Bayer)
    Abbott
    B. Braun
    ARKRAY
    Terumo
    I-SENS
    Nipro
    Omron
    Infopia
    AgaMatrix
    Smiths Medical
    Sarstedt
    SANNUO
    Yicheng
    Yuwell
    Greiner Bio One
    Edan
    Narang Medical

    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Research objectives
    To study and analyze the global Lancet and Lancing Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Lancet and Lancing Devices market by identifying its various subsegments.
    Focuses on the key global Lancet and Lancing Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Lancet and Lancing Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Direct Purchase@ https://www.qurateresearch.com/report/buy/HnM/QBI-LPI-HnM-58966/


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     

    RnM




    (EMAILWIRE.COM, October 16, 2018 ) In 2017, the global Proliferative Diabetic Retinopathy Market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Proliferative Diabetic Retinopathy market based on company, product type, application and key regions.

    This report studies the global market size of Proliferative Diabetic Retinopathy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Proliferative Diabetic Retinopathy in these regions.

    This research report categorizes the global Proliferative Diabetic Retinopathy market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

    The various contributors involved in the value chain of Proliferative Diabetic Retinopathy include manufacturers, suppliers, distributors, intermediaries, and customers.

    Request sample of the report @ https://www.reportsandmarkets.com/sample-request/global-proliferative-diabetic-retinopathy-market-insights-forecast-to-2025

    The key manufacturers in the Proliferative Diabetic Retinopathy include

    Intas Pharmaceuticals
    Santen Pharmaceutical
    Valeant Pharmaceuticals International
    Allergan Plc
    Regeneron Pharmaceuticals
    Merck KGaA
    Cipla
    Genentech, Inc. (Roche Holdings)
    Novartis
    Pfizer
    Available Discount on Report @ https://www.reportsandmarkets.com/check-discount/global-proliferative-diabetic-retinopathy-market-insights-forecast-to-2025

    Proliferative Diabetic Retinopathy Market Size Split by Type

    Anti-VEGF Agents
    Corticosteroids

    Proliferative Diabetic Retinopathy Market Size Split by Application

    Hospitals
    Clinics
    Others
    Purchase Full Report @ https://www.reportsandmarkets.com/checkout?currency=one_user-USD&report_id=2473984

    The study objectives of Proliferative Diabetic Retinopathy Market report are:

    To study and analyze the global Proliferative Diabetic Retinopathy market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Proliferative Diabetic Retinopathy market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Proliferative Diabetic Retinopathy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Proliferative Diabetic Retinopathy with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Proliferative Diabetic Retinopathy submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.
    Click Here for Any Query@ https://www.reportsandmarkets.com/enquiry/global-proliferative-diabetic-retinopathy-market-insights-forecast-to-2025

    This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Proliferative Diabetic Retinopathy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

    About Us:
    Market research is the new buzzword in the market, which helps in understanding the market potential of any product in the market. Reports And Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world.

    Contact Us:
    Sanjay Jain
    Manager - Partner Relations & International Marketing
    www.reportsandmarkets.com
    info@reportsandmarkets.com
    Ph: +44-020-3286-9338 (UK)
    Ph: +1-214-736-7666 (US)


    Sanjay jain
    12143771121
    sanjay.jain@reportsandmarkets.com

    Source: EmailWire.Com

older | 1 | .... | 1081 | 1082 | (Page 1083) | 1084 | 1085 | .... | 1118 | newer